News Instil Bio halts subject enrolment in trials due to manufacturing issues Covid-19 Russia sanctions: what next for Sputnik Covid-19 vaccine production around the world?
Features Novavax at risk of losing time advantage once Covid-19 vaccine competitors flex production muscle Reynald Castañeda
Features Multiple myeloma: first bispecific mAb to secure r/r approval will have biggest market bite Reynald Castañeda
Features Novavax Covid-19 vaccine booster: safety and manufacturing questions remain Reynald Castañeda
Comment Brexit deal secures UK access to EU’s €95.5B research and innovation programme, Horizon Europe GlobalData Healthcare
Comment Anti-GM-CSF antibodies expected to show better effect in Covid-19 than cytokine-specific targets GlobalData Healthcare
Comment Largest Covid-19 trials studying Umifenovir or traditional Chinese medicine GlobalData Healthcare
Comment Find out how pharma is fighting respiratory illnesses in the latest Pharma Technology Focus admin